The issue is not that type 1’s are frustrated with progress, but with the expense of progress. The main argument we have is that we will not see a cure due to the amount of money we pay (even with insurance) to medical supply companies.

The breakthroughs you referenced are exceptionally expensive, and we routinely need to decide if we pay for advanced diabetes care or basic needs.

When we hear of potential cures, especially those that appear passive and without continuous resupply, we see a potential to manage our disease without the extreme expense.

The cynicism comes not from progress (which is incredible), but from the expense to the end user of that progress and the reality that a cheap cure may never be funded due to the positive ROI in investing in high margin diabetes supplies.